![Regina Hodits](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Regina Hodits
Directeur/Membre du Conseil chez
AYOXXA Biosystems GmbH
Fortune : 230 $ au 31/05/2026
Profil
Regina Hodits currently serves as Director at Middle Peak Medical, Inc., TRiCares SAS, ONWARD Medical SA, GoodlifeMe AB, SNIPR Biome ApS, STipe Therapeutics ApS, Sidekick Solutions, and AYOXXA Biosystems GmbH.
Holds the position of Director at CTx Operations, Inc. since 2018.
Appointed Managing Director at Angelini Ventures SpA starting 2025.
Venture Advisor at Wellington Partners GmbH starting 2010 with title starting 2025.
Former roles include Director at FIBREX Medical, Inc. (2009–2013), U3 Pharma AG, Egalet Ltd., NovaMed Pharmaceuticals, Inc., Lumavita AG, Bicycle Therapeutics Plc, German Private Equity & Venture Capital Association, Sapiens Steering Brain Stimulation BV and GmbH, Atopix Therapeutics Ltd., Rigontec GmbH, Imcheck Therapeutics SAS, EndoStim, Inc., Oxagen Ltd., and Horizon Therapeutics Switzerland GmbH.
Independent Director at Carisma Therapeutics, Inc. (2018–2024).
Non-Executive Director at GTX medical BV.
Member-Supervisory Board at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH and ProtAffin Biotechnologie AG (2010–2014).
Member-Executive Board at Horizon Therapeutics Switzerland GmbH.
Member-Management Board at JenaValve Technology GmbH.
Venture Partner at Atlas Venture Advisors, Inc. and Atlas Venture LLP (2004–2010).
Member-Supervisory Board at Themis Bioscience GmbH (2015–2022).
Education includes graduate and doctorate degrees from Technische Universität Wien.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/05/2025 | 2 297 546 ( 5,49 % ) | 230 $ | 31/05/2026 |
Postes actifs de Regina Hodits
| Sociétés | Poste | Début |
|---|---|---|
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Private Equity Investor | 01/01/2010 |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology Provides biotechnology research and development services | Directeur/Membre du Conseil | - |
Middle Peak Medical, Inc.
 Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Develops implants for treatment of mitral valve disease | Directeur/Membre du Conseil | - |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Directeur/Membre du Conseil | - |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Directeur/Membre du Conseil | 01/06/2018 |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Directeur/Membre du Conseil | - |
GoodlifeMe AB
 GoodlifeMe AB Packaged SoftwareTechnology Services Develops digital health products | Directeur/Membre du Conseil | - |
SNIPR Biome ApS
 SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Directeur/Membre du Conseil | - |
Sidekick Solutions | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Regina Hodits
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Regina Hodits
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
35
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 35 |
|---|---|
FIBREX Medical, Inc.
 FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bio-pharmaceutical research development services | Commercial Services |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
EndoStim, Inc.
 EndoStim, Inc. Medical SpecialtiesHealth Technology Develops electro medical devices to treat gastrointestinal neuromuscular disorders | Health Technology |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Atlas Venture LLP
 Atlas Venture LLP Investment ManagersFinance Atlas Venture is a leading international venture capital investment manager specialized in sectors including life sciences, communications and information technology and investing in Europe and the US. The firm targets early-stage, science-based businesses and leads the first financing round, generally acquiring a significant minority stake which grants them board representation. They subsequently help recruiting a management team to carry the emerging business forward, typically towards international expansion. Atlas Venture also invests in later-stage operations such as corporate spin-offs and down financing. Investment criteria include leadership potential in a global high-growth market, market momentum and a proprietary disruptive technology or business model. In the technology industry, Atlas Venture focuses on components, systems, software and services. The group has invested in data warehousing, storage systems for digital media, core chips for mobile phones and MEMS-based displays for mobile devices. Their biotechnology investments focus on drug discovery. They have invested in blood-thinning agents, small interfering RNA, emerging cancer drugs and anti-infectives. Atlas Venture sources deals though a combination of top-down global market analysis and bottom-up local connections in their industries of choice, including contacts in the academic world. Their exit strategies are international and include M&A transactions and IPOs on a variety of exchanges. | Finance |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
NovaMed Pharmaceuticals, Inc.
 NovaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology Provides transcatheter valve implantation systems | Health Technology |
ProtAffin Biotechnologie AG
 ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Lumavita AG
 Lumavita AG Medical/Nursing ServicesHealth Services Develops and commercializes antiinfectives for women's health | Health Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases | Health Technology |
Technische Universität Wien
 Technische Universität Wien Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
German Private Equity & Venture Capital Association
 German Private Equity & Venture Capital Association Investment ManagersFinance Operates as a venture capital firm | Finance |
Sapiens Steering Brain Stimulation BV
 Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Develops medical devices | Electronic Technology |
Sapiens Steering Brain Stimulation GmbH
 Sapiens Steering Brain Stimulation GmbH Medical SpecialtiesHealth Technology Develops steering deep brain stimulation (DBS) solutions | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology Provides biotechnology research and development services | Health Technology |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel class of medicines to treat atopic dermatitis and severe asthma | Health Technology |
Middle Peak Medical, Inc.
Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Develops implants for treatment of mitral valve disease | Health Technology |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases | Health Technology |
TRiCares SAS
 TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
GTX medical BV
 GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
GoodlifeMe AB
GoodlifeMe AB Packaged SoftwareTechnology Services Develops digital health products | Technology Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Health Technology |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Health Technology |
Sidekick Solutions | |
Angelini Ventures SpA
 Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements. | Finance |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
